Live Antivirals News with Latest Updates

Live antivirals news and developments with the latest updates. Check out current antivirals news stories and find out what happened, what is going on with antivirals. Recent news updates about antivirals
NACCHO message on World Hepatitis Day 2021: “Hep Can’t Wait”
Winter viruses and COVID-19 could push NHS to breaking point, warns new report
What underlies inconsistent results in clinical trials for COVID-19 drugs?
Mefloquine: A promising drug ‘soldier’ in battle against COVID-19
New study finds SARS-CoV-2 can infect testes
New AI model helps understand virus spread from animals to humans
Malaysia registers first hepatitis C treatment developed through South-South cooperation
Protein identified as new therapeutic anti-viral target for COVID-19
Eddie Gray appointed chair of Antivirals Taskforce
Penn Researchers Discover Drug that Blocks Multiple SARS-CoV-2 Variants in Mice
Health and Social Care Secretary’s statement on coronavirus 27 May 2021
SARS-CoV-2 RNA discovery unlocks new potential treatments
City of Hope and Griffith University develop direct-acting antiviral to treat COVID-19
Researchers develop direct-acting antiviral to treat COVID-19
University of Alberta lab reveals how a much-needed oral antiviral drug confuses replication machinery of SARS-CoV-2
Scientists develop better way to block viruses that cause childhood respiratory infections
Blocking viruses’ exit strategy
Hepatitis C drugs combined with Remdesivir show strong effectiveness against covid-19
Drug development platform could provide flexible, rapid and targeted antimicrobials
UK Government launches COVID-19 Antivirals Taskforce to roll out innovative home treatments this autumn
Preparing for future pandemics
Experimental antiviral proves effective in halting spread and damage of COVID-19
Newly launched British biotech company pioneers ground-breaking potential treatments for COVID-19
Can we guarantee supply of essential drugs in a global crisis?
Three Common Antiviral Drugs Potentially Effective Against COVID-19
Pfizer Initiates Phase 1 Study of Novel Oral Antiviral Therapeutic Agent Against SARS-CoV-2
Targeting a new antibody supersite key to COVID immunity
Viruses Mutate, But Treatments Are Static. Is There a Way to Change That?
Tracing and controlling High Pathogenicity Avian Influenza
Great achievements after five years of hepatitis C elimination – but more work needed
Lessons from flu season
Scientists uncover potential antiviral treatment for Covid-19
Scientists Discover How Remdesivir Works to Inhibit Coronavirus
WHO on progress in access to hepatitis C diagnostics and treatment
Warfarin and other blood thinners – reminder on safe use during COVID-19 pandemic
Transforming Waste into Bio-Based Chemicals
Common HIV drugs increase a type of immunity in gut
Designed antiviral proteins inhibit SARS-CoV-2 in lab
COVID-19 coronavirus spike holds infectivity details